Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
$47.48
+1.7%
$56.06
$37.29
$62.61
$21.04B1.51.29 million shs1.74 million shs
Corning Incorporated stock logo
GLW
Corning
$45.35
+1.0%
$49.92
$30.72
$55.33
$38.84B1.035.42 million shs6.32 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.73
-1.0%
$26.28
$24.48
$31.54
$145.79B0.6140.13 million shs37.26 million shs
Seagen Inc. stock logo
SGEN
Seagen
$228.74
$228.74
$123.77
$228.96
$42.93B0.321.48 million shs86 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
+1.78%-12.07%-17.54%-17.82%+12.55%
Corning Incorporated stock logo
GLW
Corning
+0.97%-3.75%-14.47%-6.71%+37.87%
Pfizer Inc. stock logo
PFE
Pfizer
-1.05%-0.78%-0.54%+1.40%-8.16%
Seagen Inc. stock logo
SGEN
Seagen
0.00%0.00%0.00%0.00%0.00%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
4.4098 of 5 stars
3.32.00.82.83.42.51.9
Corning Incorporated stock logo
GLW
Corning
3.8699 of 5 stars
3.43.01.70.02.92.51.9
Pfizer Inc. stock logo
PFE
Pfizer
4.8876 of 5 stars
2.33.04.24.22.83.33.1
Seagen Inc. stock logo
SGEN
Seagen
0.7349 of 5 stars
0.00.00.02.50.63.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
2.53
Moderate Buy$56.7119.43% Upside
Corning Incorporated stock logo
GLW
Corning
2.86
Moderate Buy$53.0016.88% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.50
Moderate Buy$31.9224.09% Upside
Seagen Inc. stock logo
SGEN
Seagen
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest BAM, PFE, SGEN, and GLW Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/12/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
2/14/2025
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
2/14/2025
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy
2/13/2025
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Perform$50.00 ➝ $53.00
2/13/2025
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Outperform ➝ Outperform$63.00 ➝ $62.50
2/13/2025
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$55.00 ➝ $54.00
2/10/2025
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$64.00 ➝ $66.00
2/10/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$33.00 ➝ $33.00
2/3/2025
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Outperform ➝ Sector Outperform$59.50 ➝ $63.00
1/30/2025
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform$63.00 ➝ $70.00
1/30/2025
Corning Incorporated stock logo
GLW
Corning
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
(Data available from 3/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
$3.98B5.29$4.40 per share10.78$5.05 per share9.40
Corning Incorporated stock logo
GLW
Corning
$13.12B2.96$3.11 per share14.57$12.92 per share3.51
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.29$4.03 per share6.38$15.81 per share1.63
Seagen Inc. stock logo
SGEN
Seagen
$2.30B18.66N/AN/A$15.10 per share15.15
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
$2.17B$1.3235.9723.861.9254.47%81.16%60.52%5/14/2025 (Estimated)
Corning Incorporated stock logo
GLW
Corning
$506M$0.5878.1916.611.503.86%15.10%6.13%4/29/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.4118.248.490.6412.62%19.47%8.09%4/29/2025 (Estimated)
Seagen Inc. stock logo
SGEN
Seagen
-$610.31M-$4.01N/AN/AN/A-32.61%-28.06%-20.92%N/A

Latest BAM, PFE, SGEN, and GLW Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/12/2025Q4 2024
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
$0.39$0.40+$0.01$0.42$1.27 billionN/A
2/4/2025Q4 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.48$0.63+$0.15$0.07$17.26 billion$17.76 billion
1/29/2025Q4 2024
Corning Incorporated stock logo
GLW
Corning
$0.56$0.57+$0.01$0.36$3.76 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
$1.753.69%N/A132.58%N/A
Corning Incorporated stock logo
GLW
Corning
$1.122.47%+5.27%193.10%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.69%+2.50%121.99%16 Years
Seagen Inc. stock logo
SGEN
Seagen
N/AN/AN/AN/AN/A

Latest BAM, PFE, SGEN, and GLW Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/12/2025
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
quarterly$0.43752.7%2/28/20252/28/20253/31/2025
2/12/2025
Corning Incorporated stock logo
GLW
Corning
quarterly$0.282.2%2/28/20252/28/20253/28/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
N/A
0.94
0.94
Corning Incorporated stock logo
GLW
Corning
0.62
1.62
1.07
Pfizer Inc. stock logo
PFE
Pfizer
0.63
1.00
0.73
Seagen Inc. stock logo
SGEN
Seagen
N/A
2.67
2.12

Institutional Ownership

CompanyInstitutional Ownership
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
68.41%
Corning Incorporated stock logo
GLW
Corning
69.80%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Seagen Inc. stock logo
SGEN
Seagen
84.26%

Insider Ownership

CompanyInsider Ownership
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
11.00%
Corning Incorporated stock logo
GLW
Corning
0.40%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
Seagen Inc. stock logo
SGEN
Seagen
25.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Brookfield Asset Management Ltd. stock logo
BAM
Brookfield Asset Management
2,400443.14 millionN/AOptionable
Corning Incorporated stock logo
GLW
Corning
49,800856.56 million853.14 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.67 billion5.66 billionOptionable
Seagen Inc. stock logo
SGEN
Seagen
3,256187.70 million139.08 millionOptionable

Recent News About These Companies

Seagen posts breast cancer win ahead of Pfizer takeover
Is Merck planning a $30bn-plus move for Seagen?
Franklin Biotechnology Discovery C
Pfizer: Turning The Corner (Rating Upgrade)
MRNA Feb 2024 64.000 put
MRNA Feb 2024 77.000 call
MRNA Feb 2024 67.000 put

New MarketBeat Followers Over Time

Media Sentiment Over Time

Brookfield Asset Management stock logo

Brookfield Asset Management NYSE:BAM

$47.48 +0.77 (+1.66%)
Closing price 03/12/2025 03:59 PM Eastern
Extended Trading
$51.08 +3.60 (+7.58%)
As of 03/12/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Brookfield Asset Management Ltd. is a real estate investment firm specializing in alternative asset management services. Its renewable power and transition business includes the operates in the hydroelectric, wind, solar, distributed generation, and sustainable solution sector. The company's infrastructure business engages in the utilities, transport, midstream, and data infrastructure sectors. In addition, its private equity business offers industrial, infrastructure, and business services sectors; and real estate business, which includes housing, logistics, hospitality, science and innovation, office, and retail sectors. Further, it provides credit business; and insurance solution in the reinsurance, annuities, operating platform, and investment solutions sectors. Brookfield Asset Management Ltd. was incorporated in 2022 and is headquartered in Toronto, Canada.

Corning stock logo

Corning NYSE:GLW

$45.35 +0.44 (+0.97%)
Closing price 03/12/2025 03:58 PM Eastern
Extended Trading
$46.12 +0.77 (+1.70%)
As of 03/12/2025 06:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Corning Incorporated engages in the display technologies, optical communications, environmental technologies, specialty materials, and life sciences businesses in the United States and internationally. The company's Display Technologies segment offers glass substrates for flat panel displays, including liquid crystal displays and organic light-emitting diodes that are used in televisions, notebook computers, desktop monitors, tablets, and handheld devices. Its Optical Communications segment provides optical fibers and cables; and hardware and equipment products, such as cable assemblies, fiber optic hardware and connectors, optical components and couplers, closures, network interface devices, and other accessories for the telecommunications industry, businesses, governments, and individuals. The company's Specialty Materials segment manufactures products that offer material formulations for glass, glass ceramics, crystals, precision metrology instruments, and software, as well as glass wafers and substrates, tinted sunglasses, and radiation shielding products for various markets comprising mobile consumer electronics, semiconductor equipment optics and consumables, aerospace and defense optics, radiation shielding products, sunglasses, and telecommunications components. Its Environmental Technologies segment provides ceramic substrates and filter products for emissions control in mobile, gasoline, and diesel applications. The company's Life Sciences segment offers laboratory products, including consumables, such as plastic vessels, liquid handling plastics, specialty surfaces, cell culture media, and serum, as well as general labware, and glassware and equipment under the Corning, Pyrex, Falcon, and Axygen brands. The company was formerly known as Corning Glass Works and changed its name to Corning Incorporated in April 1989. Corning Incorporated was founded in 1851 and is headquartered in Corning, New York.

Pfizer stock logo

Pfizer NYSE:PFE

$25.72 -0.27 (-1.02%)
Closing price 03/12/2025 03:59 PM Eastern
Extended Trading
$25.76 +0.03 (+0.12%)
As of 03/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Seagen stock logo

Seagen NASDAQ:SGEN

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. It offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of adult patients with advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-TGT and SEA-CD70 for various cancer diseases. It has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington. As of December 14, 2023, Seagen Inc. operates as a subsidiary of Pfizer Inc.